DoubleVerify Holdings, Inc. (DV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
DV PRNewsWire — July 07, 2025LOS ANGELES , July 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to DoubleVerify Holdings, Inc. ("DoubleVerify" or the "Company") (NYSE: DV) have opportunity to lead the securities fraud class action lawsuit.

MicroStrategy Incorporated (MSTR) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
MSTR PRNewsWire — July 07, 2025Shareholders with losses of $100,000 or more are encouraged to contact the firm. LOS ANGELES , July 7, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against MicroStrategy Incorporated d/b/a Strategy ("Strategy" or the "Company") (NASDAQ: MSTR).

Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit — Neutral
HIMS GlobeNewsWire — July 07, 2025LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”).

Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
ELV PRNewsWire — July 07, 2025LOS ANGELES , July 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Elevance Health, Inc. ("Elevance" or the "Company") (NYSE: ELV) have opportunity to lead the securities fraud class action lawsuit.

Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit — Neutral
IOVA PRNewsWire — July 07, 2025LOS ANGELES , July 7, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) have opportunity to lead the securities fraud class action lawsuit.

WTW appoints Alena Kharkavets as Head of Claims in North America — Neutral
WTW GlobeNewsWire — July 07, 2025NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a global advisory, broking and solutions company, today announced that Alena Kharkavets has been appointed North American Head of Claims in its Insurance Consulting and Technology (ICT) business.

Deadline Alert: Vestis Corporation (VSTS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit — Neutral
VSTS GlobeNewsWire — July 07, 2025LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming August 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) securities between May 2, 2024, to May 6, 2025, inclusive (the “Class Period”).

Liberty All-Star® Growth Fund, Inc. Declares Distribution — Neutral
ASG Business Wire — July 07, 2025BOSTON--(BUSINESS WIRE)--The Board of Directors of Liberty All-Star Growth Fund, Inc. (NYSE: ASG) has declared a distribution of $0.12 per share payable on September 2, 2025 to shareholders of record on July 18, 2025. This distribution is in accordance with the Fund's current distribution policy of paying distributions on its shares totaling approximately 8 percent of its net asset value per year, payable in four quarterly installments of 2 percent. A portion of the distribution may be treated.

Deadline Soon: Compass Group Diversified Holdings (CODI) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit — Neutral
CODI Business Wire — July 07, 2025LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 8, 2025 deadline to participate as a lead plaintiff in the securities fraud class action lawsuit filed on behalf of investors who acquired Compass Group Diversified Holdings (“Compass” or the “Company”) (NYSE: CODI) securities between February 24, 2022 and May 7, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO LOST MONEY ON COMPASS GROUP DIVERSIFIED HOLDINGS (CODI), CLICK HERE.

Transaction in Own Shares 7 July, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 7 July, 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 07/07/2025 1,121,793 £25.7950 £25.4250 £25.5846 LSE GBP 07/07/2025 155,410 £25.8400 £25.4250 £25.5968 Chi-X (CXE) GBP 07/07/2025 102,797 £25.7650 £25.4350 £25.5619 BATS (BXE) GBP 07/07/2025 938,534 €30.1050 €29.5900 …

Visa's Partnerships With BNPL Players: Smart Hedge or Future Risk? — Positive
V Zacks Investment Research — July 07, 2025V teams up with BNPL firms like Klarna and Afterpay to stay central in payments as credit habits shift.

Top 3D Printing Stocks to Strengthen Your Portfolio and Maximize Returns — Positive
PRLB SSYS XMTR Zacks Investment Research — July 07, 20253D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like CRS, ATI, GE and LHX offer strong growth potential.

Affluent Investors Double Allocations to Alternative Investments, HSBC Investor Snapshot Finds — Neutral
HSBC Business Wire — July 07, 2025NEW YORK--(BUSINESS WIRE)--HSBC's new Affluent Investor Snapshot 2025 reveals that affluent investors doubled their allocations to alternative investments over the past year. The trend looks set to continue, holding strong appeal into the future as investors seek to further diversify their portfolios. Around half of the global affluent investors in the survey of 10,797 individuals in 12 markets say they plan to own alternative investments within the next 12 months, doubling the current ownershi.

Shares of Mustang Bio (NASDAQ: MBIO) surged on Monday as investors responded to a significant approval from the Food and Drug Administration (FDA).

Apogee Therapeutics reports positive Phase 2 results for atopic dermatitis drug — Positive
APGE Proactive Investors — July 07, 2025Apogee Therapeutics (NASDAQ:APGE) shares fell almost 15% despite the release of positive Phase 2 APEX trial results for APG777, its anti-IL-13 antibody for moderate-to-severe atopic dermatitis. The trial met its primary endpoint with a 71% reduction in Eczema Area Severity Index (EASI) score at Week 16, versus 33.8% for placebo.

Howmet Aerospace Stock Surges 65.6% YTD: Is It Still Worth Buying? — Positive
HWM Zacks Investment Research — July 07, 2025HWM soars 65.6% YTD on aerospace and defense strength, but investors must weigh growth prospects against rich valuation.

Musk Needs to Focus on Tesla, Not Trump, Says Azoria CEO — Negative
TSLA Bloomberg Technology — July 07, 2025Azoria CEO James Fishback says Elon Musk should focus his time on Tesla and SpaceX and not trying to sabotage President Donald Trump. Fishback, a shareholder, says if Musk doesn't want to be a fulltime CEO, he "should tell us now.

PETCO HEALTH AND WELLNESS COMPANY, INC. (NASDAQ: WOOF) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Petco Health and Wellness Company, Inc. Investors of Upcoming Deadline — Neutral
WOOF GlobeNewsWire — July 07, 2025NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Petco Health and Wellness Company, Inc. (“Petco” or the “Company”) (NASDAQ: WOOF) investors of an upcoming deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join This Class Action Lawsuit?

Uncertainty creates value opportunities. In this article, I highlight two value stocks trading far below their historical valuations. Both offer dividend yields that are well above historical average and strong growth potential. Both stocks exemplify how investors can secure decent yields and future upside by buying quality companies when market sentiment is overly pessimistic.
